Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of G(i/o)-coupled receptors: Changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation

Molecular Pharmacology

Volumn 57, Issue 4, 2000, Pages 820-825

  Bayewitch, Michael L ^a   Nevo, Igal ^a   Avidor Reiss, Tomer ^a   Levy, Rivka ^a   Simonds, William F ^b   Vogel, Zvi ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CHOLIC ACID; DETERGENT; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; MUSCARINIC M4 RECEPTOR; OPIATE AGONIST; PERTUSSIS TOXIN;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; INTERNALIZATION; NONHUMAN; OPIATE ADDICTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SOLUBILITY; WESTERN BLOTTING;

EID: 0034029962     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.57.4.820     Document Type: Article

References (38)

1. sa. Mol Pharmacol 52:993-999.
2. Aronin N and DiFiglia M (1992) The subcellular localization of the G-protein Gi alpha in the basal ganglia reveals its potential role in both signal transduction and vesicle trafficking, J Neurosci 12:3435-3444.
3. Attali B and Vogel Z (1989) Long-term opiate exposure leads to reduction of the αi-subunit of GTP-binding proteins. J Neurochem 53:1636-1639.
4. Avidor-Reiss T, Bayewitch M, Levy R, Matus-Leibovitch N, Nevo I and Vogel Z (1995a) Adenylylcyclase supersensitization in μ-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J Biol Chem 270: 29732-29738.
5. Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T and Vogel Z (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation. J Biol Chem 271:21309-21315.
6. Avidor-Reiss T, Nevo I, Saya D, Bayewitch M and Vogel Z (1997) Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem 272:5040-5047.
7. κ-Opioid receptor-transfected cell lines: Modulation of adenylyl cyclase activity following acute and chronic opioid treatments. FEBS Lett 361:70-74.
8. Bayewitch ML, Avidor-Reiss T, Levy R, Pfeuffer T, Nevo I, Simonds WF and Vogel Z (1998a) Differential modulation of adenylyl cyclases I and II by various Gβ subunits. J Biol Chem 273:2273-2276.
9. βy subunits. FASEB J 12:1019-1025.
10. 2-adrenergic receptor that impair coupling to G8 interfere with receptor down-regulation but not sequestration. Mol Pharmacol 39:192-198.
11. Carman CV, Lisanti MP and Benovic JL (1999) Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem 274:8858-8864.
12. Chen J and Rasenick M (1995) Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content. J Pharmacol Exp Ther 275:509-517.
13. Clapham DE and Neer EJ (1997) G protein βγ subunits. Annu Rev Pharmacol Toxicol 37:167-203.
14. Crespo P, Xu N, Simonds W and Gutkind J (1994) Ras-dependent activaton of MAP kinase pathway mediated by G-protein βγ subunits. Nature (Lond) 369:418-420.
15. de Weerd WFC and Leeb-Lundberg LMF (1997) Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Gα subunits Gαq and Gαi in caveolae in DDT1 MF-2 smooth muscle cells. J Biol Chem 272:17858-17866.
16. i-protein βγ subunits. Nature (Lond) 356:159-161.
17. Goldsmith P, Gierschik P, Milligan G, Unson CG, Vinitsky R, Malech HL and Spiegel AM (1987) Antibodies directed against synthetic peptides distinguish between GTP-binding proteins in neutrophil and brain. J Biol Chem 262:14683-14688.
18. 2+ channels by G-protein βγ subunits. Nature (Lond) 380:258-262.
19. Huang C, Hepler JR, Chen LT, Gilman AG, Anderson RGW and Mumby SM (1997) Organization of G proteins and adenylyl cyclase at the plasma membrane. Mol Biol Cell 8:2365-2378.
20. Krupnick JG and Benovic JL (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289-319.
21. Kurzchalia T, Hartman E and Dupree P (1995) Guilt by insolubility - Does a protein's detergent insolubility reflect caveolar location? Trends Cell Biol 5:187-189
22. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I and Lisanti MP (1995) Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 270:15693-15701.
23. Nestler EJ, Hope BT and Widnell KL (1993) Drug addiction: A model for the molecular basis of neural plasticity. Neuron 11:995-1006.
24. Nevo I, Avidor-Reiss T, Levy R, Bayewitch M, Heldman E and Vogel Z (1998) Regulation of adenylyl cyclase isozymes upon acute and chronic activation of inhibitory receptors. Mol Pharmacol 54:419-426.
25. Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S and Millan MJ (1999) G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5′-O-(3-[35S]thio)-triphosphate binding and antibody study. Mol Pharmacol 55:564-574.
26. Northup JK, Sternweis PC, Smigel MD, Schleifer LS, Ross EM and Gilman AG (1980) Purification of the regulatory component of adenylate cyclase. Proc Natl Acad Sci USA 11:6516-6520.
27. Palmer TM, Harris CA, Coote J and Stiles GL (1997) Induction of multiple effects on adenylyl cyclase regulation by chronic activation of the human A3 adenosine receptor. Mol Pharmacol 52:632-640.
28. Pitcher JA, Freedman NJ and Lefkowitz RJ (1998) G protein-coupled receptor kinases. Annu Rev Biochem 67:653-692.
29. Raynor K, Kong H, Hines J, Kong G, Benovic J, Yasuda K, Bell GI and Reisine T (1994) Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. J Pharmacol Exp Ther 1381:-1386.
30. Roychowdhury S and Rasenick M (1997) G protein β1γ2 subunits promote microtubule assembly. J Biol Chem 272:31576-31581.
31. Sharma SK, Klee WA and Nirenberg M (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc Natl Acad Sci USA 72:3092-3096.
32. Simonds WF, Butrysnki JE, Gautam N, Unson CG and Spiegel AM (1991) G-protein βγ dimers: Membrane targeting requires subunit coexpression and intact γ C-A-A-X domain. J Biol Chem 266:5363-5366.
33. Simonds WF, Goldsmith PK, Woodard CJ, Unson CG and Spiegel AM (1989) Receptor and effector interactions of Gs. Functional studies with antibodies to the alpha s carboxyl-terminal decapeptide. FEBS Lett 249:289-294.
34. Stan RV, Roberts WG, Predescu D, Ihida K, Saucan L, Ghitescu L and Palade GE (1996) Immunoisolation and partial characterization of endothelial plasmalemmal vesicles (caveolae). Mol Biol Cell 8:595-605.
35. Thomas JM and Hoffman BB (1996) Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: Role of βγ subunits in transducing enhanced activity of the type VI isoform. Mol Pharmacol 49:907-914.
36. van Vliet BJ, De Vries TJ, Wardeh G, Mulder AH and Schoffelmeer ANM (1991) μ-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure. Eur J Pharmacol 208:105-111.
37. Varma R and Mayor S (1998) GPI-anchored proteins are organized in submicron domains at the cell surface. Nature (Lond) 394:798-801.
38. 2 by the α and βγ subunits of trimeric GTP-binding protein. Proc Natl Acad Sci USA 90:5297-5301.